Saturday 17 October 2026 Export AMRX’s income statement to Excel — free account

AMNEAL PHARMACEUTICALS, INC.

AMRX Healthcare Drug Manufacturers Specialty & Generic

AMNEAL PHARMACEUTICALS, INC.’s revenue for fiscal 2025 (year ended December 2025) was $3.0 billion, up 8.05% from fiscal 2024. In the quarter to June 2026, revenue grew 9.89%, EPS grew 157.1%, free cash flow fell 351.4% and total debt rose 8.22%, each against the same quarter a year earlier. Revenue growth for five consecutive years.

19.18 0.07 −0.36%

Follow AMRX

Alert me

Market cap: $6.2B
P/E: 38.4×
Fwd P/E: 51.6×
Dividend yield: —
F-score: 7/9
Altman Z: 1.94
Beneish M: −2.68
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
ROE Full definition →	(395.84%)	(137.24%)	(79.69%)	(5.80%)	+8 more TTM periods Free account
Piotroski F-Score Full definition →	7	7	7	7
ROA Full definition →	4.37%	3.54%	2.01%	0.17%
ROIC Full definition →	11.05%	11.44%	11.25%	10.04%
Return on Tangible Assets Full definition →	10.35%	8.06%	4.89%	0.42%
Average Days of Receivables Full definition →	119.51	102.02	108.29	110.25
Free Cash Flow per Share Full definition →	(0.04)	0.60	0.73	0.76
Free Cash Flow Full definition →	(11.59)	189.67	227.73	237.88
Capital Expenditures Full definition →	(212.37)	(116.17)	(112.26)	(89.87)
Other line items
Cash ROIC Full definition →	(0.41%)	6.82%	8.10%	8.81%
Accounts Receivable Turnover Full definition →	3.41	3.79	3.61	3.57
Accounts Payable Turnover Full definition →	2.73	2.89	2.55	2.65
Inventory Turnover Full definition →	2.94	3.01	3.13	3.07
Average Days of Payables Full definition →	139.15	129.52	145.83	143.92
Days of Inventory on Hand Full definition →	130.81	125.35	116.14	120.85
Tax Rate Full definition →	0.07	0.00	(0.08)	(0.16)
Research and Development Expense of Revenue Full definition →	5.63%	6.06%	6.17%	7.01%
Selling, General and Administrative Expense of Revenue Full definition →	18.34%	17.97%	17.45%	17.34%
Share Based Compensation of Revenue Full definition →	1.14%	1.10%	1.06%	1.05%
Interest Coverage Full definition →	2.00	1.83	1.63	1.45
Operating CF/Net income Full definition →	1.28	2.50	4.72	55.55
Depreciation/Fixed assets Full definition →	0.46	0.51	0.56	0.61
Capex/Depreciation Full definition →	(1.01)	(0.51)	(0.46)	(0.34)
Revenue per Share Full definition →	9.77	9.64	9.63	9.34
Operating CF per Share Full definition →	0.63	0.97	1.09	1.04
Capex per Share Full definition →	(0.67)	(0.37)	(0.36)	(0.29)
Capex to Sales Full definition →	0.07	0.04	0.04	0.03

Show all line items

Columns are period end dates

Stockrow Weekly